XML 23 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Restatement of Previously Issued Financial Statements
 9 Months Ended
Sep. 30, 2022
Restatement of Previously Issued Financial Statements [Abstract]  
Restatement of Previously Issued Financial Statements
Note J - Restatement of Previously Issued Financial Statements

During the quarter ended March 31, 2022, the Company determined that in March 2021, pursuant to an agreement with New York University (“NYU”), ownership of all of the gamma knife equipment at the NYU Medical Center transferred from the Company to NYU, resulting in the recognition of a gain on the sale and transfer of the gamma knife property on the Company’s December 31, 2021 income tax returns. The Company previously received insurance proceeds with the Gamma Knife facility, which was destroyed as a result of flooding from Hurricane Sandy. For tax purposes, the resulting gain becomes taxable when the replacement property is sold or disposed of, which occurred in 2021. As a result, the Company recorded this tax liability and restated its consolidated financial statements as of and for the year ended December 31, 2021 and each of the quarters during the year ended December 31, 2021 on Form 10-K/A for the year ended December 31, 2021.


The restatement tables below present a reconciliation from the previously reported to the restated values as of and for the three and nine months ended September 30, 2021. The values as previously reported were derived from the Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 filed on November 19, 2021.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three Months Ended September 30, 2021
   
As previously
    
Restatement
        
   
Reported
    
Impacts
    
As Restated
  
Income tax provision
  
$
(8,000
)
  
$
24,000
    
$
16,000
  
Net loss
  
$
(344,000
)
  
$
(8,000
)
  
$
(352,000
)
Basic and diluted net loss per share
  
$
(0.04
)
  
$
(0.01
)
  
$
(0.05
)

CONDENSED CONSOLIDATD STATEMENTS OF OPERATIONS
For the Nine Months Ended September 30, 2021

Income tax provision
  
$
(202,000
)
  
$
702,000
    
$
500,000
  
Net loss
  
$
(378,000
)
  
$
(299,000
)
  
$
(677,000
)
Basic and diluted net loss per share
  
$
(0.05
)
  
$
(0.04
)
  
$
(0.09
)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Nine Months Ended September 30, 2021
Net loss
  
$
(378,000
)
  
$
(299,000
)
  
$
(677,000
)
Change in: Income taxes receivable/payable
  
$
197,000
    
$
299,000
    
$
496,000